1.
Purification and biochemical character of a fibrinolytic protein from Ampullarum crossean
福寿螺纤溶活性蛋白的纯化及性质研究
2.
The inhibitory effects and immunoregulatory activity of the fibrinolytic protein from Eupolyphaga sinensis Walker (EFP) in vivo on line H22 in mice
地鳖纤溶活性蛋白对H22荷瘤小鼠的抑瘤作用
3.
Cloning and Expression of Eupolyphaga sinensis Walker Fibrinolytic Protein cDNA in Pichia pastoris
地鳖虫纤溶活性蛋白cDNA序列克隆与毕赤酵母表达
4.
Study on Extraction of Active Protein from Scolopendra subspinipes mutilans and its Fibrinolytic Activity
少棘蜈蚣活性蛋白提取及纤溶作用性质研究
5.
The Correlation of Fibrinolytic Activation, Lipoprotein(a) and Coronary Arterial Thrombosis;
纤溶活性、脂蛋白a与冠脉血栓形成的关系研究
6.
Detection of serum lipoprotein (α) level and fibrinolytic activity in patients with silent cerebral infarction
无症状性脑梗死患者血清脂蛋白(α)水平与纤溶活性检测
7.
Thrombin is an enzyme that catalyzes the conversion of the soluble plasma protein fibrinogen to the insoluble protein fibrin.
凝血酶能催化可溶性血浆纤维蛋白转化为不溶性的纤维蛋白。
8.
an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents.
血浆中血纤维蛋白溶酶不活跃的前体，能被有机溶剂转化成血纤维蛋白溶酶。
9.
fibrinolytic syndrome
纤维蛋白溶解综合征
10.
The inactive precursor to plasmin that is found in body fluids and blood plasma.
血纤维蛋白溶酶原血纤维蛋白溶酶不活跃的前体，常发现于体液和血浆中
11.
Study on the Levels of Thrombin Activable Fibrinolysis Inhibitor Active(TAFIa) in the Patients with Hemophilia
血友病患者凝血酶激活的纤维蛋白溶解抑制物活性(TAFIa)的检测及其临床意义
12.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
13.
The Study of Relationships between Serum C-Reactive Protein、the Activity of Fibrinolytic System in Acute Cerebral Infarction and Different Type of Syndrome of TCM;
急性脑梗死患者血清C-反应蛋白、纤溶系统活性与中医辨证分型的关系研究
14.
The Relationship of LN-R and uPA in Invasive Ductal Breast Cancer
层粘连蛋白受体、尿激酶型纤溶酶原激活物在乳腺浸润性导管癌中的表达及其相关性
15.
Effects of Acute Exercise on Blood Conagulation and Fibrinolysis;
急性运动对血液凝固和纤维蛋白溶解的影响
16.
Influences of different Collagen Protein Solution′s pH value on Modification of Silk Fiber
溶液pH值对胶原蛋白改性真丝纤维的影响
17.
Plasma Concentrations of Matrix Metalloproteinase-9 and Plasminogen Activator Inhibitor-1 in Acute Coronary Syndromes;
急性冠脉综合征金属蛋白酶-9与纤溶酶原激活物抑制物-1的关系研究
18.
Role of Tissue-Type Plasminogen Activator in Neonatal Rat with Hypoxia-Ischemia Brain Damage
组织纤维蛋白溶酶原激活剂在新生大鼠缺氧缺血性脑损伤中的作用